Results 1 to 10 of about 107,630 (133)

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2 [PDF]

open access: yesJournal of Translational Medicine, 2022
Background JAK1 and JAK2 have been implicated in fibrosis and cancer as a fibroblast-related marker; however, their role in liver fibrosis has not been elucidated.
Zhenghui Song   +8 more
doaj   +2 more sources

IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway [PDF]

open access: yesBiomedicines, 2021
Blood–retinal barrier (BRB) dysfunction underlies macular oedema in many sight-threatening conditions, including diabetic macular oedema, neovascular age-related macular degeneration and uveoretinitis.
Eimear M. Byrne   +5 more
doaj   +2 more sources

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2018
Background Vitiligo is a chronic autoimmune disease in which the destruction of melanocytes causes white spots on the affected skin. Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals ...
Asmaa Gaber Abdou   +3 more
doaj   +2 more sources

The Janus kinase 1 is critical for pancreatic cancer initiation and progression [PDF]

open access: yesCell Reports
Summary: Interleukin-6 (IL-6)-class inflammatory cytokines signal through the Janus tyrosine kinase (JAK)/signal transducer and activator of transcription (STAT) pathway and promote the development of pancreatic ductal adenocarcinoma (PDAC); however, the
Hridaya Shrestha   +13 more
doaj   +2 more sources

Successful Treatment of Severe Nail Lichen Planus with Janus Kinase 1 Inhibitor Abrocitinib [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Yingzhi Luo,1,* Jian Wu,2,* Xingyun Zhao,1,* Ping Yang,1 Yunmi Qiu,1 Liming Wu,1 Jianbo Zhong1 1Department of Dermatology, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang ...
Luo Y   +6 more
doaj   +2 more sources

Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression [PDF]

open access: yesCell Reports, 2018
Summary: Janus kinases (JAKs) and their downstream STAT proteins play key roles in cytokine signaling, tissue homeostasis, and cancer development. Using a breast cancer model that conditionally lacks Janus kinase 1, we show here that JAK1 is essential ...
Barbara L. Wehde   +5 more
doaj   +2 more sources

Nitric Oxide Induces a Janus Kinase-1-Dependent Inflammatory Response in Primary Murine Astrocytes [PDF]

open access: yesASN Neuro, 2021
Nitric oxide (NO) is a versatile free radical that has been implicated in many biological processes (i.e., vasodilation, neurotransmission, and smooth muscle relaxation).
John D. Nowery   +3 more
doaj   +2 more sources

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives [PDF]

open access: yesPsoriasis: Targets and Therapy, 2019
Karen Ly,1 Kristen M Beck,1 Mary P Smith,1 Ana-Maria Orbai,2 Wilson Liao11Department of Dermatology, University of California San Francisco, San Francisco, CA, USA; 2Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USACorrespondence ...
Ly K   +4 more
doaj   +2 more sources

Successful Treatment of Nail Lichen Planus by the Janus Kinase 1 Upadacitinib and Literature Review [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Xingyun Zhao,1,* Jianbo Zhong,1,* Yanzhen Xu,2 Yingzhi Luo,1 Yunmi Qiu,1 Liming Wu,1 Ping Yang1 1Department of Dermatology, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, People’s
Zhao X   +6 more
doaj   +2 more sources

Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions [PDF]

open access: yesFrontiers in Immunology, 2020
BackgroundCutaneous lupus erythematosus (CLE) is an interferon (IFN) -driven autoimmune skin disease characterized by an extensive cytotoxic lesional inflammation with activation of different innate immune pathways.
Tanja Fetter   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy